53
Participants
Start Date
October 27, 2010
Primary Completion Date
October 24, 2012
Study Completion Date
October 24, 2012
Anagrelide Hydrochloride
Subjects will be started at 1.0 mg per day and titrated as necessary.
Akita University Hospital, Akita
Juntendo University Hospital, Hongo 3-1-3
Tokyo Metropolitan Cancer and Infectious diseases Center Kom, Honkomagome 3-18-22
Nippon Medical School Hospital, Sendagi 1-1-5
Chiba University Hospital, Chuo-ku Inohana 1-8-1
NHO Nagoya Medical Center, Nagoya
Hokkaido University Hospital, Sapporo
Juntendo University Shizuoka Hospital, Nagaoka
Tokai University Hospital, Isehara-shi
Osaka City University Hospital, Osaka
Gunma University Hospital, Showa-machi 3-39-15
NHO Tokyo Medical Center, Higashigaoka 2-5-1
Mie University Hospital, Tsu
University of Miyazaki Hospital, Miyazaki
Niigata Cancer Center Hospital, Chuo-ku Kawagishi-cho 2-15-3
Okayama University Hospital, Okayama
Osaka University Hospital, Suita-shi
Tokushima University Hospital, Tokushima
Keio University Hospital, Tokyo
Lead Sponsor
Shire
INDUSTRY